|
1
|
Angus DC and van der Poll T: Severe sepsis
and septic shock. N Engl J Med. 369:840–851. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Singer M, Deutschman CS, Seymour CW,
Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche
JD, Coopersmith CM, et al: The third international consensus
definitions for sepsis and septic shock (Sepsis-3). JAMA.
315:801–810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cao Z and Robinson RA: The role of
proteomics in understanding biological mechanisms of sepsis.
Proteomics Clin Appl. 8:35–52. 2014. View Article : Google Scholar
|
|
4
|
Hamers L, Kox M and Pickkers P:
Sepsis-induced immunoparalysis: Mechanisms, markers, and treatment
options. Minerva Anestesiol. 81:426–439. 2015.
|
|
5
|
Chun K, Syndergaard C, Damas C, Trubey R,
Mukindaraj A, Qian S, Jin X, Breslow S and Niemz A: Sepsis pathogen
identification. J Lab Autom. 20:539–561. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tacke F and Zimmermann HW: Macrophage
heterogeneity in liver injury and fibrosis. J Hepatol.
60:1090–1096. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ge X, Feng Z, Xu T, Wu B, Chen H, Xu F, Fu
L, Shan X, Dai Y, Zhang Y and Liang G: A novel imidazopyridine
derivative, X22, attenuates sepsis-induced lung and liver injury by
inhibiting the inflammatory response in vitro and in vivo. Drug Des
Devel Ther. 10:1947–1959. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang C, Wang J, Chen Z, Wang Y and Zhang
W: 2-Phenylethynesulfonamide prevents induction of pro-inflammatory
factors and attenuates LPS-induced liver injury by targeting
NHE1-Hsp70 complex in mice. PLoS One. 8:e675822013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Scott MJ, Liu S, Shapiro RA, Vodovotz Y
and Billiar TR: Endotoxin uptake in mouse liver is blocked by
endotoxin pretreatment through a suppressor of cytokine
signaling-1-dependent mechanism. Hepatology. 49:1695–1708. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang JB, Wang HT, Li LP, Yan YC, Wang W,
Liu JY, Zhao YT, Gao WS and Zhang MX: Development of a rat model of
D-galactosamine/lipopolysaccharide induced hepatorenal syndrome.
World J Gastroenterol. 21:9927–9935. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Unsicker K, Spittau B and Krieglstein K:
The multiple facets of the TGF-β family cytokine
growth/differentiation factor-15/macrophage inhibitory cytokine-1.
Cytokine Growth Factor Rev. 24:373–384. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hijazi Z, Oldgren J, Andersson U, Connolly
SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Yusuf S, Siegbahn A and
Wallentin L: Growth-differentiation factor 15 and risk of major
bleeding in atrial fibrillation: Insights from the randomized
evaluation of long-term anticoagulation therapy (RE-LY) trial. Am
Heart J. 190:94–103. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cotter G, Voors AA, Prescott MF, Felker
GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Milo O, Hua
TA, et al: Growth differentiation factor 15 (GDF-15) in patients
admitted for acute heart failure: Results from the RELAX-AHF study.
Eur J Heart Fail. 17:1133–1143. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abulizi P, Loganathan N, Zhao D, Mele T,
Zhang Y, Zwiep T, Liu K and Zheng X: Growth differentiation
factor-15 deficiency augments inflammatory response and exacerbates
septic heart and renal injury induced by lipopolysaccharide. Sci
Rep. 7:10372017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan D, Liu HL, Yu ZJ, Huang YH, Gao D, Hao
H, Liao SS, Xu FY and Zhou XY: BML-111 protected LPS/D-GalN-induced
acute liver injury in rats. Int J Mol Sci. 17:pii: E1114. 2016.
View Article : Google Scholar
|
|
16
|
Dai L, Cui X, Zhang X, Cheng L, Liu Y,
Yang Y, Fan P, Wang Q, Lin Y, Zhang J, et al: SARI inhibits
angiogenesis and tumour growth of human colon cancer through
directly targeting cerulo-plasmin. Nat Commun. 7:119962016.
View Article : Google Scholar
|
|
17
|
t'Hart BA, Vervoordeldonk M, Heeney JL and
Tak PP: Gene therapy in nonhuman primate models of human autoimmune
disease. Gene Ther. 10:890–901. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mikic AN, Brkic S, Maric D, Sekulic B,
Cetkovic A and Mitic G: Thiobarbituric acid reactive substances as
marker of oxidative stress in pregnancies with pre-eclampsia. Med
Pregl. 64:377–380. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu MW, Liu R, Wu HY, Zhang W, Xia J, Dong
MN, Yu W, Wang Q, Xie FM, Wang R, et al: Protective effect of
Xuebijing injection on D-galactosamine- and
lipopolysaccharide-induced acute liver injury in rats through the
regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing
TIPE2 expression. Int J Mol Med. 38:1419–1432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim JM, Kosak JP, Kim JK, Kissling G,
Germolec DR, Zeldin DC, Bradbury JA, Baek SJ and Eling TE:
NAG-1/GDF15 transgenic mouse has less white adipose tissue and a
reduced inflammatory response. Mediators Inflamm. 2013:6418512013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar
|
|
23
|
Ratnam NM, Peterson JM, Talbert EE, Ladner
KJ, Rajasekera PV, Schmidt CR, Dillhoff ME, Swanson BJ, Haverick E,
Kladney RD, et al: NF-kappaB regulates GDF-15 to suppress
macrophage surveillance during early tumor development. J Clin
Invest. 127:3796–3809. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bootcov MR, Bauskin AR, Valenzuela SM,
Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor
K, et al: MIC-1, a novel macrophage inhibitory cytokine, is a
divergent member of the TGF-beta superfamily. Proc Natl Acad Sci
USA. 94:11514–11519. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu DD and Mei YA: Effects of growth
differentiation factor-15 (GDF-15) on neurological systems,
cardiovascular diseases, and cancer progression. Sheng Li Xue Bao.
69:109–121. 2017.In Chinese. PubMed/NCBI
|
|
26
|
Sandor N, Schilling-Toth B, Kis E, Benedek
A, Lumniczky K, Safrany G and Hegyesi H: Growth differentiation
factor-15 (GDF-15) is a potential marker of radiation response and
radiation sensitivity. Mutat Res Genet Toxicol Environ Mutagen.
793:142–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Unal B, Alan S, Bassorgun CI, Karakas AA,
Elpek GO and Ciftcioglu MA: The divergent roles of growth
differentiation factor-15 (GDF-15) in benign and malignant skin
pathologies. Arch Dermatol Res. 307:551–557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou YM, Li MJ, Zhou YL, Ma LL and Yi X:
Growth differentiation factor-15 (GDF-15), novel biomarker for
assessing atrial fibrosis in patients with atrial fibrillation and
rheumatic heart disease. Int J Clin Exp Med. 8:21201–21207.
2015.
|
|
29
|
Kahli A, Guenancia C, Zeller M, Grosjean
S, Stamboul K, Rochette L, Girard C and Vergely C: Growth
differentiation factor-15 (GDF-15) levels are associated with
cardiac and renal injury in patients undergoing coronary artery
bypass grafting with cardiopulmonary bypass. PLoS One.
9:e1057592014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee ES, Kim SH, Kim HJ, Kim KH, Lee BS and
Ku BJ: Growth differentiation factor 15 predicts chronic liver
disease severity. Gut Liver. 11:276–282. 2017. View Article : Google Scholar :
|
|
31
|
Buendgens L, Yagmur E, Bruensing J,
Herbers U, Baeck C, Trautwein C, Koch A and Tacke F: Growth
differentiation factor-15 is a predictor of mortality in critically
Ill patients with sepsis. Dis Markers. 5271203:20172017.
|
|
32
|
Hoque R, Farooq A and Mehal WZ: Sterile
inflammation in the liver and pancreas. J Gastroenterol Hepatol.
28(Suppl 1): S61–S67. 2013. View Article : Google Scholar
|
|
33
|
Mehal WZ: The inflammasome in liver injury
and non-alcoholic fatty liver disease. Dig Dis. 32:507–515. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ambade A, Catalano D, Lim A and Mandrekar
P: Inhibition of heat shock protein (molecular weight 90 kDa)
attenuates proinflammatory cytokines and prevents
lipopolysaccharide-induced liver injury in mice. Hepatology.
55:1585–1595. 2012. View Article : Google Scholar :
|
|
35
|
Baranova IN, Souza AC, Bocharov AV,
Vishnyakova TG, Hu X, Vaisman BL, Amar MJ, Chen Z, Kost Y, Remaley
AT, et al: Human SR-BI and SR-BII potentiate
lipopolysaccharide-induced inflammation and acute liver and kidney
injury in mice. 196:3135–3147. 2016.
|
|
36
|
Liao WQ, Qi YL, Wang L, Dong XM, Xu T,
Ding CD, Liu R, Liang WC, Lu LT, Li H, et al: Recql5 protects
against lipopolysaccharide/D-galactosamine-induced liver injury in
mice. J Immunol. 21:10375–10384. 2015.
|
|
37
|
Zhang J, Xu L, Zhang L, Ying Z, Su W and
Wang T: Curcumin attenuates
D-galactosamine/lipopolysaccharide-induced liver injury and
mitochondrial dysfunction in mice. J Nutr. 144:1211–1218. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yan J and Li S and Li S: The role of the
liver in sepsis. Int Rev Immunol. 33:498–510. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dixon LJ, Barnes M, Tang H, Pritchard MT
and Nagy LE: Kupffer cells in the liver. Compr Physiol. 3:785–797.
2013.PubMed/NCBI
|
|
40
|
Tsutsui H and Nishiguchi S: Importance of
Kupffer cells in the development of acute liver injuries in mice.
Int J Mol Sci. 15:7711–7730. 2014. View Article : Google Scholar : PubMed/NCBI
|
